-
1
-
-
0024146204
-
C1 inhibitor and hereditary angioneurotic edema
-
Davis AE III. C1 inhibitor and hereditary angioneurotic edema. Ann Rev Immunol 1988; 6:595-628.
-
(1988)
Ann Rev Immunol
, vol.6
, pp. 595-628
-
-
Davis III, A.E.1
-
2
-
-
0017077229
-
Hereditary angioedema: The clinical syndrome and its management
-
Frank MM, Gelfand JA, Atkinson JP. Hereditary angioedema: the clinical syndrome and its management. Ann Int Med 1976; 84:580-93.
-
(1976)
Ann Int Med
, vol.84
, pp. 580-593
-
-
Frank, M.M.1
Gelfand, J.A.2
Atkinson, J.P.3
-
3
-
-
0024423930
-
1-antitrypsin for structure and function of serpins
-
1-antitrypsin for structure and function of serpins. Biochemistry 1989; 28:8951-66.
-
(1989)
Biochemistry
, vol.28
, pp. 8951-8966
-
-
Huber, R.1
Carrell, R.W.2
-
4
-
-
0018873523
-
Protein inhibitors of proteinases
-
Laskowski M Jr, Kato I. Protein inhibitors of proteinases. Ann Rev Biochem 1980; 49:593-626.
-
(1980)
Ann Rev Biochem
, vol.49
, pp. 593-626
-
-
Laskowski Jr., M.1
Kato, I.2
-
5
-
-
0020643467
-
Human plasma proteinase inhibitors
-
Travis J, Salvesen GS. Human plasma proteinase inhibitors. Ann Rev Biochem 1983; 52:655-709.
-
(1983)
Ann Rev Biochem
, vol.52
, pp. 655-709
-
-
Travis, J.1
Salvesen, G.S.2
-
6
-
-
0020067533
-
The in vivo metabolism of antithrombin III and antithrombin III complexes
-
Shifman MA, Pizzo SV. The in vivo metabolism of antithrombin III and antithrombin III complexes. J Biol Chem 1982; 257:3243-8.
-
(1982)
J Biol Chem
, vol.257
, pp. 3243-3248
-
-
Shifman, M.A.1
Pizzo, S.V.2
-
7
-
-
0025191834
-
Turnover of *I-Protein C inhibitor and *I-αi-antitrypsin and their complexes with activated protein C
-
Laurell M, Stenflo J, Carlson TH. Turnover of *I-Protein C inhibitor and *I-αi-antitrypsin and their complexes with activated protein C. Blood 1990; 76:2290-5.
-
(1990)
Blood
, vol.76
, pp. 2290-2295
-
-
Laurell, M.1
Stenflo, J.2
Carlson, T.H.3
-
9
-
-
0025828198
-
2-antiplasmin, angiotensinogen, and ovalbumin
-
2-antiplasmin, angiotensinogen, and ovalbumin. Biochemistry 1991; 30:1723-30.
-
(1991)
Biochemistry
, vol.30
, pp. 1723-1730
-
-
Mast, A.E.1
Enghild, J.J.2
Pizzo, S.V.3
Salvesen, G.4
-
10
-
-
0023950380
-
In vivo catabolism of heparin cofactor II and its complex with thrombin: Evidence for a common receptor-mediated clearance pathway for three serine proteinase inhibitors
-
Pratt CW, Church FC, Pizzo SV. In vivo catabolism of heparin cofactor II and its complex with thrombin: evidence for a common receptor-mediated clearance pathway for three serine proteinase inhibitors. Arch Biochem Biophys 1988; 262:111-7.
-
(1988)
Arch Biochem Biophys
, vol.262
, pp. 111-117
-
-
Pratt, C.W.1
Church, F.C.2
Pizzo, S.V.3
-
11
-
-
0025873532
-
Evidence for a tetrahedral intermediate complex during serpin-proteinase interactions
-
Matheson NR, van Halbeek H, Travis J. Evidence for a tetrahedral intermediate complex during serpin-proteinase interactions. J Biol Chem 1991; 266:13489-91.
-
(1991)
J Biol Chem
, vol.266
, pp. 13489-13491
-
-
Matheson, N.R.1
Van Halbeek, H.2
Travis, J.3
-
12
-
-
0025336126
-
Identification of a serpin-enzyme complex receptor on human hepatoma cells and human monocytes
-
Perlmutter DH, Glover GI, Rivetna M, Schasteen CS, Fallon RJ, Identification of a serpin-enzyme complex receptor on human hepatoma cells and human monocytes. Proc Natl Acad Sci USA 1990; 87:3753-7.
-
(1990)
Proc Natl Acad Sci USA
, vol.87
, pp. 3753-3757
-
-
Perlmutter, D.H.1
Glover, G.I.2
Rivetna, M.3
Schasteen, C.S.4
Fallon, R.J.5
-
13
-
-
0024453908
-
Serpin receptor 1: A hepatic receptor that mediates the clearance of antithrombin III-proteinase complexes
-
Pizzo SV. Serpin receptor 1: a hepatic receptor that mediates the clearance of antithrombin III-proteinase complexes. Am J Med 1989; 87 (Suppl. 3B):10s-14s.
-
(1989)
Am J Med
, vol.87
, Issue.SUPPL. 3B
-
-
Pizzo, S.V.1
-
16
-
-
0027470437
-
Clearance of human native proteinase-complexed, and proteolytically inactivated Cl-inhibitor in rats
-
de Smet BJGL, de Boer JP, Agterberg J, Rigter G, Bleeker WK, Hack CE. Clearance of human native proteinase-complexed, and proteolytically inactivated Cl-inhibitor in rats. Blood 1993; 81:56-61.
-
(1993)
Blood
, vol.81
, pp. 56-61
-
-
De Smet, B.J.G.L.1
De Boer, J.P.2
Agterberg, J.3
Rigter, G.4
Bleeker, W.K.5
Hack, C.E.6
-
18
-
-
0024412729
-
A new simplified procedure for Cl inhibitor purification. A novel use for jacalinagarose
-
Pilatte Y, Hammer CH, Frank MM, Fries LF. A new simplified procedure for Cl inhibitor purification. A novel use for jacalinagarose. J Immunol Methods 1989; 120:37-43.
-
(1989)
J Immunol Methods
, vol.120
, pp. 37-43
-
-
Pilatte, Y.1
Hammer, C.H.2
Frank, M.M.3
Fries, L.F.4
-
20
-
-
0020380627
-
A new solid-state reagent to iodinate proteins. I. Conditions for the efficient labeling of antiserum
-
Markwell MAK. A new solid-state reagent to iodinate proteins. I. Conditions for the efficient labeling of antiserum. Analyt Biochem 1982; 125:427-31.
-
(1982)
Analyt Biochem
, vol.125
, pp. 427-431
-
-
Markwell, M.A.K.1
-
21
-
-
36149059384
-
131I labeled plasma proteins
-
131I labeled plasma proteins. Phys Med Biol 1957; 2:36-53.
-
(1957)
Phys Med Biol
, vol.2
, pp. 36-53
-
-
Matthews, C.M.E.1
-
22
-
-
0020682111
-
Behavior in vivo of normal and dysfunctional Cl inhibitor in normal subjects and patients with hereditary angioneurotic edema
-
Quastel M, Harrison R, Cicardi M, Alper CA, Rosen FS. Behavior in vivo of normal and dysfunctional Cl inhibitor in normal subjects and patients with hereditary angioneurotic edema. J Clin Invest 1983; 71:1041-6.
-
(1983)
J Clin Invest
, vol.71
, pp. 1041-1046
-
-
Quastel, M.1
Harrison, R.2
Cicardi, M.3
Alper, C.A.4
Rosen, F.S.5
-
23
-
-
46149128444
-
Prolonged vascular retention of a hemoglobin solution modified by cross-linking with 2-nor-2 formylpyridoxal 5́-phosphate
-
Bleeker WK, van der Plas J, Agterberg J, Rigter G, Bakker JC. Prolonged vascular retention of a hemoglobin solution modified by cross-linking with 2-nor-2 formylpyridoxal 5́-phosphate. J Lab Clin Med 1986; 108:448-54.
-
(1986)
J Lab Clin Med
, vol.108
, pp. 448-454
-
-
Bleeker, W.K.1
Van Der Plas, J.2
Agterberg, J.3
Rigter, G.4
Bakker, J.C.5
-
24
-
-
0025871316
-
Pharmacokinetics of activated protein C in guinea pigs
-
Berger Jr H, Kirstein CG, Orthner CL. Pharmacokinetics of activated protein C in guinea pigs. Blood 1991; 77:2174-84.
-
(1991)
Blood
, vol.77
, pp. 2174-2184
-
-
Berger Jr., H.1
Kirstein, C.G.2
Orthner, C.L.3
-
25
-
-
0347922052
-
Life-span of plasma coagulation factors
-
Williams WJ, Beutler E, Erslav AJ, Lichtman MA, eds. New York: McGraw-Hill
-
Comp PC. Life-span of plasma coagulation factors. In: Williams WJ, Beutler E, Erslav AJ, Lichtman MA, eds. Hematology. New York: McGraw-Hill, 1990:1290-4.
-
(1990)
Hematology
, pp. 1290-1294
-
-
Comp, P.C.1
-
26
-
-
0020672314
-
Ligand binding, conformational change and plasma elimination of human, mouse and rat alpha-macroglobulin proteinase inhibitors
-
Gonias SL, Balber AE, Hubbard WJ, Pizzo SV. Ligand binding, conformational change and plasma elimination of human, mouse and rat alpha-macroglobulin proteinase inhibitors. Biochem J 1983; 209:99-105.
-
(1983)
Biochem J
, vol.209
, pp. 99-105
-
-
Gonias, S.L.1
Balber, A.E.2
Hubbard, W.J.3
Pizzo, S.V.4
-
29
-
-
0025003236
-
Crystal structure of ovalbumin as a model for the reactive centre of serpins
-
Stein PE, Leslie AGW, Finch JT, Turnell WG, McLaughlin PJ, Carrell RW. Crystal structure of ovalbumin as a model for the reactive centre of serpins. Nature 1990; 347:99-102.
-
(1990)
Nature
, vol.347
, pp. 99-102
-
-
Stein, P.E.1
Leslie, A.G.W.2
Finch, J.T.3
Turnell, W.G.4
McLaughlin, P.J.5
Carrell, R.W.6
-
30
-
-
0026546881
-
Structural basis of latency in plasminogen activator inhibitor-1
-
Mottonen J, Strand A, Symersky J et al. Structural basis of latency in plasminogen activator inhibitor-1. Nature 1992; 355:270-3.
-
(1992)
Nature
, vol.355
, pp. 270-273
-
-
Mottonen, J.1
Strand, A.2
Symersky, J.3
-
31
-
-
0028367551
-
The intact and cleaved human antithrombin III complex as a model for serpin-proteinase interactions
-
Schreuder HA, de Boer B, Dijkema R, Mulders J, Theunissen HJM, Grottenhuis PDJ, Hol WGJ. The intact and cleaved human antithrombin III complex as a model for serpin-proteinase interactions. Struct Biol 1994; 1:48-54.
-
(1994)
Struct Biol
, vol.1
, pp. 48-54
-
-
Schreuder, H.A.1
De Boer, B.2
Dijkema, R.3
Mulders, J.4
Theunissen, H.J.M.5
Grottenhuis, P.D.J.6
Hol, W.G.J.7
-
32
-
-
0028407364
-
Crystal structure of an uncleaved serpin reveals the conformation of an inhibitory reactive loop
-
Wei A, Rubin H, Cooperman BS, Christianson DW. Crystal structure of an uncleaved serpin reveals the conformation of an inhibitory reactive loop. Struct Biol 1994; 1:251-8.
-
(1994)
Struct Biol
, vol.1
, pp. 251-258
-
-
Wei, A.1
Rubin, H.2
Cooperman, B.S.3
Christianson, D.W.4
-
33
-
-
0027491244
-
Cl inhibitorserine proteinase complexes and the biosynthesis of Cl-inhibitor by HepG2 and U937 cells
-
Patston PA, Medcalf RL, Kourteva Y, Schapira M. Cl inhibitorserine proteinase complexes and the biosynthesis of Cl-inhibitor by HepG2 and U937 cells. Blood 1993; 82:3371-9.
-
(1993)
Blood
, vol.82
, pp. 3371-3379
-
-
Patston, P.A.1
Medcalf, R.L.2
Kourteva, Y.3
Schapira, M.4
-
34
-
-
0025143104
-
Identification of determinants involved in binding of tissue-type plasminogen activator-plasminogen activator inhibitor type 1 complexes to HepG2 cells
-
Morton PA, Owensby DA, Wun TC, Billadello JJ, Schwartz AL. Identification of determinants involved in binding of tissue-type plasminogen activator-plasminogen activator inhibitor type 1 complexes to HepG2 cells. J Biol Chem 1990; 265:14093-9.
-
(1990)
J Biol Chem
, vol.265
, pp. 14093-14099
-
-
Morton, P.A.1
Owensby, D.A.2
Wun, T.C.3
Billadello, J.J.4
Schwartz, A.L.5
|